0 CHECKOUT

PRODUCT FILTERS

REGION

2,219
1,442
1,439
1,349
1,349

COUNTRY

1,334
147
89
87
86

CATEGORIES

  • 336
  • 322
  • 262
  • 248
  • 215
  • 196
  • 194
  • 159
  • 150
  • 145
  • 144
  • 134
  • 110
  • 104
  • 49

PRICE

571
1,190
2,190
4,921

PUBLISHED

248
462
2,564
4,921

PRODUCT TYPE

4,053
363
261
189
52
2
1

Oncology Drugs Market Research Reports

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

Global Melanoma Diagnostics and Therapeutics Market - Segmented by type of cancer and Geography (2015-2020)

The global melanoma diagnostics and therapeutics market was valued at USD 2,662 million in 2015 and is expected to reach USD 5,450 million by 2020. Melanoma is one of the serious types of skin cancer...

Published:  January 2016
Price:  From

Global Ovarian Cancer Diagnostics and therapeutics market - segmented by type of cancer and geography (2015-2020)

The global market for ovarian cancer diagnostics and therapeutics accounted for USD 1,106 million in 2015 and is anticipated to grow at a CAGR OF 10-16% till 2020. Ovarian cancer is caused by an...

Published:  January 2016
Price:  From

Global Bladder Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and geography (2015-2020)

Bladder cancer is a urologic malignancy arising from the epithelial lining of the urinary bladder. It is the ninth most common cancer worldwide in men and women, with the highest recurrence rate. Though...

Published:  January 2016
Price:  From

Global Pancreatic Cancer Therapeutics & Diagnostics Market - Segmented by type of cancer and geography (2015-2020)

Pancreatic cancer is a disease in which cancer cells generate in the tissues of the pancreas. Globally, pancreatic cancer is the 12th most common cancer in men and 11th most common cancer in women....

Published:  January 2016
Price:  From

Global Kidney Cancer Therapeutics & Diagnostics Market - Segmented by type of cancer and geography (2015-2020)

The frequency of kidney cancer, worldwide, has increased in the recent years. Changes in lifestyle, excessive smoking, increased consumption of alcohol and a rise in obesity because of sedentary life...

Published:  January 2016
Price:  From

Global Liver cancer Market - Segmented by type, technology, end-user and geography (2015 - 2020)

Analysts forecast the Global Liver Cancer Market to grow at a CAGR of 7-15% over the period, 2015-2020. The market is currently valued at USD 707 million, as per 2015. Liver cancer represents the...

Published:  January 2016
Price:  From

Fisetin (CAS 528-48-3) Market Research Report 2016

This Global Report 2016 is a result of industry experts’ diligent work on researching the world market of fisetin. The report helps to build up a clear view of the market (trends and prospects), identify...

Published:  February 2016
Price: 

North America Melanoma Diagnostics and Therapeutics Market - Segmented by type of cancer and Geography (2015-2020)

The North America melanoma diagnostics and therapeutics market was valued at USD 1,460 million in 2015 and is expected to reach USD 2,889 million by 2020. Melanoma is one of the serious types of...

Published:  January 2016
Price:  From

Middle East and Africa Melanoma Diagnostics and Therapeutics Market - Segmented by type of cancer and Geography (2015-2020)

The Middle East & Africa melanoma diagnostics and therapeutics market was valued at USD 66 million in 2015 and is expected to reach USD 147 million by 2020. Melanoma is one of the serious types of...

Published:  January 2016
Price:  From

Latin America Pancreatic Cancer therapeutics & Diagnostics Market - Segmented by type of cancer and geography (2015-2020)

Pancreatic cancer is a disease in which cancer cells generate in the tissues of the pancreas. Globally, pancreatic cancer is the 12th most common cancer in men and 11th most common cancer in women....

Published:  January 2016
Price:  From

Latin America Bladder Bladder Cancer Therapeutics & Diagnostics market - Segmented by type of cancer and geography (2015-2020)

Bladder cancer is a urologic malignancy arising from the epithelial lining of the urinary bladder. It is the ninth most common cancer worldwide in men and women, with the highest recurrence rate. Though...

Published:  January 2016
Price:  From

Europe Uterine cancer therapeutics & Diagnostics Market - Segmented by type of cancer and geography (2015-2020)

Uterine cancer is a common form of cancer of the female reproductive system that initiates in the lining of the uterus. According to the American Cancer Society, around 47,130 new cases of endometrial...

Published:  January 2016
Price:  From

Asia-Pacific Uterine cancer therapeutics & Diagnostics Market - Segmented by type of cancer and geography (2015-2020)

Uterine cancer is a common form of cancer of the female reproductive system that initiates in the lining of the uterus. According to the American Cancer Society, around 47,130 new cases of endometrial...

Published:  January 2016
Price:  From

Middle East & Africa l Uterine cancer therapeutics & Diagnostics Market - Segmented by type of cancer and geography (2015-2020)

Uterine cancer is a common cancer of the female reproductive system that initiates in the lining of the uterus. According to the American Cancer Society, around 47,130 new cases of endometrial cancer...

Published:  January 2016
Price:  From

Middle East & Africa Kidney Cancer Therapeutics & Diagnostics Market - Segmented by type of cancer and geography (2015-2020)

The frequency of kidney cancer, worldwide, has increased in the recent years. Changes in lifestyle, excessive smoking, increased consumption of alcohol and a rise in obesity because of sedentary life...

Published:  January 2016
Price:  From

South America Ovarian Cancer Diagnostics and therapeutics market - segmented by type of cancer and geography (2015-2020)

The Latin American market for ovarian cancer diagnostics and therapeutics accounted for USD 44 million in 2015 and is anticipated to grow at a CAGR of 10-16% till 2020. Ovarian cancer is caused by...

Published:  January 2016
Price:  From

Europe Kidney Cancer Therapeutics & Diagnostics Market - Segmented by type of cancer and geography (2015-2020)

The frequency of kidney cancer, worldwide, has increased in the recent years. Changes in lifestyle, excessive smoking, increased consumption of alcohol and a rise in obesity because of sedentary life...

Published:  January 2016
Price:  From

Asia-Pacific Kidney Cancer Therapeutics & Diagnostics Market - Segmented by type of cancer and geography (2015-2020)

The frequency of kidney cancer, worldwide, has increased in the recent years. Changes in lifestyle, excessive smoking, increased consumption of alcohol and a rise in obesity because of sedentary life...

Published:  January 2016
Price:  From

Middle East & Africa Bladder Cancer Therapeutics & Diagnostics market - Segmented by type of cancer and geography (2015-2020)

Bladder cancer is a urologic malignancy arising from the epithelial lining of the urinary bladder. It is the ninth most common cancer worldwide in men and women, with the highest recurrence rate. Though...

Published:  January 2016
Price:  From

Asia-Pacific Bladder cancer Therapeutics & Diagnostics Market- Segmented by type of cancer and geography (2015-2020)

Bladder cancer is a urologic malignancy, arising from the epithelial lining of the urinary bladder. It is the ninth most common cancer worldwide in men and women, with the highest recurrence rate. Though...

Published:  January 2016
Price:  From
Loading Indicator

Our Clients